These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23051058)

  • 1. Measles still spreads in Europe: who is responsible for the failure to vaccinate?
    Carrillo-Santisteve P; Lopalco PL
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():50-6. PubMed ID: 23051058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is measles elimination possible in WHO European region up to 2015?
    Paslawska A; Mrozek-Budzyn D
    Przegl Epidemiol; 2013; 67(3):451-4, 553-5. PubMed ID: 24340559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The end of measles and congenital rubella: an achievable dream?
    Adamo G; Sturabotti G; D'Andrea E; Baccolini V; Romano F; Iannazzo S; Marzuillo C; Villari P
    Ann Ig; 2017; 29(1):1-26. PubMed ID: 28067934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased transmission and outbreaks of measles--European Region, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1605-10. PubMed ID: 22129994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Feb; 54(7):175-8. PubMed ID: 15729220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The State of Measles and Rubella in the WHO European region.
    Muscat M; Ben Mamou M; Shefer A; Jankovic D; Deshevoy S; Butler R
    Rev Esp Salud Publica; 2015; 89(4):345-51. PubMed ID: 26580789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of epidemiological studies for progress of measles elimination].
    Mrozek-Budzyn D
    Przegl Epidemiol; 2010; 64(3):361-6. PubMed ID: 20976947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress towards measles elimination, Philippines, 1998–2014.
    Wkly Epidemiol Rec; 2015 Apr; 90(15):149-59. PubMed ID: 25864232
    [No Abstract]   [Full Text] [Related]  

  • 10. Progress towards measles elimination in Singapore.
    Ho HJ; Low C; Ang LW; Cutter JL; Tay J; Chan KP; Ooi PL; Thoon KC; Goh KT
    Vaccine; 2014 Dec; 32(51):6927-6933. PubMed ID: 25444818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles and rubella in the World Health Organization European region: diversity creates challenges.
    Spika JS; Wassilak S; Pebody R; Lipskaya G; Deshevoi S; Guris D; Emiroglu N
    J Infect Dis; 2003 May; 187 Suppl 1():S191-7. PubMed ID: 12721913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Measles, mumps, and rubella vaccine. Resurgence of measles in Europe].
    Garcés-Sánchez M; Renales-Toboso M; Bóveda-García M; Díez-Domingo J
    Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):673-8. PubMed ID: 26611100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress toward the 2012 measles elimination goal--Western Pacific Region, 1990-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jun; 58(24):669-73. PubMed ID: 19553903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hot spot: epidemiology of measles and rubella in Germany and the WHO European region].
    Matysiak-Klose D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1231-7. PubMed ID: 23990084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P; Bechini A; Boccalini S; Peruzzi M; Tiscione E; Boncompagni G; Mannelli F; Salmaso S; Filia A; Ciofi degli Atti M
    Vaccine; 2007 Apr; 25(16):3105-10. PubMed ID: 17306425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the elimination of measles and congenital rubella in Central Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Panatto D; Amicizia D; Bonanni P
    Hum Vaccin Immunother; 2013 Mar; 9(3):649-56. PubMed ID: 23292174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why does measles persist in Europe?
    Plans-Rubió P
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1899-1906. PubMed ID: 28550369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in the elimination of measles and rubella in the WHO European Region].
    Muscat M; Jankovic D; Goel A; Butler R; Pfeifer D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1225-30. PubMed ID: 23990083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.